Robert Parks
CIK 1707662 · Chief Accounting Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$840.2K
Companies
5
Total Filings
38
Lifetime Open-Market Net
-$1.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FTRE | Chief Accounting Officer | 20,389 | $20.70 | $422.1K | -$123.4K | 7 | 2026-05-20 |
| NTAP | Chief Accounting Officer | 0 | $174.53 | $0 | -$691.7K | 14 | 2023-08-30 |
| Syneos Health, Inc. (SYNH) Delisted | EVP, Chief Accounting Officer | 10,903 | $42.98 | $468.6K | -$178.1K | 7 | 2021-01-20 |
| IQV | Sr Vice President, Controller | 1,721 | $242.94 | $418.1K | -$203.0K | 4 | 2018-08-06 |
| Q | Sr Vice President, Controller | — | $127.89 | — | $0 | 1 | 2017-05-25 |
Recent Filings · Page 3 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-17 | NTAP | Mixed | +591 | $11.7K | EDGAR |
| 2022-07-06 | NTAP | Mixed | +326 | $19.9K | EDGAR |
| 2022-05-16 | NTAP | Mixed | +1,059 | -$31.4K | EDGAR |
| 2022-02-17 | NTAP | Mixed | +2,178 | -$88.8K | EDGAR |
| 2021-07-06 | NTAP | Grant (A) | — | $0 | EDGAR |
| 2021-02-19 | NTAP | Grant (A) | — | $0 | EDGAR |
| 2021-01-20 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −405 | -$31.2K | EDGAR |
| 2021-01-11 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −679 | -$50.0K | EDGAR |
| 2020-12-04 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −660 | -$41.3K | EDGAR |
| 2020-04-21 | Syneos Health, Inc. (SYNH) Delisted | Mixed | −3,211 | -$161.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.